Curaleaf Holdings (CURLF) Tax Rate (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Tax Rate of 344.77% for Q1 2026, down 54997.0% year-on-year from N/an in Q1 2025, and up 74.01% on a QoQ basis from 1326.74% in Q4 2025.
Curaleaf Holdings (CURLF) Tax Rate (2019 - 2026) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Tax Rate for 8 consecutive years, with 344.77% the latest figure, recorded in Q1 2026.
- Quarterly Tax Rate fell 54997.0% year-over-year to 344.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 291.61% (down 20312.0% YoY) and the FY2025 annual result came in at 158.14%, down 7147.0% from the prior year.
- Tax Rate rose to 344.77% in Q1 2026 per CURLF's latest filing, from 1326.74% in the prior quarter.
- Over the last five years, Tax Rate for CURLF reached as high as 1293.9% in Q1 2023 and fell as low as 1326.74% in Q4 2025.
- A 5-year average of 2.04% and a median of 88.61% in 2023 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2022 — Tax Rate surged 169918 bps — and 2025, when it tumbled 104947 bps.
- Year by year, Tax Rate stood at 5.43% in 2022, then plunged by 190 bps to 4.91% in 2023, then plunged by 5552 bps to 277.27% in 2024, then sank by 379 bps to 1326.74% in 2025, then jumped by 74 bps to 344.77% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 344.77%, 1326.74%, and 124.4% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 15.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.71% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -23.33% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 13.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 171.33% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 19.81% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 34.48% |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | -344.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -344.77% |
| Mar 31, 2026 | -344.77% |
| Mar 31, 2026 | -344.77% |
| Dec 31, 2025 | -1,326.74% |
| Dec 31, 2025 | -1,326.74% |
| Dec 31, 2025 | -1,326.74% |
| Sep 30, 2025 | 124.40% |
| Sep 30, 2025 | 124.40% |
| Sep 30, 2025 | 124.40% |
| Jun 30, 2025 | 163.26% |
| Jun 30, 2025 | 163.26% |
| Jun 30, 2025 | 163.26% |
| Mar 31, 2025 | 205.20% |
| Mar 31, 2025 | 205.20% |
| Mar 31, 2025 | 205.20% |
| Dec 31, 2024 | -277.27% |
| Dec 31, 2024 | -277.27% |
| Dec 31, 2024 | -277.27% |
| Sep 30, 2024 | 276.40% |
| Sep 30, 2024 | 276.40% |